Nyxoah Sa stock is traded at $0.8131, with a volume of 73,741. It is up +0.26% in the last 24 hours and down -43.14% over the past month. Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.
Previous Close:
$0.811
Open:
$0.83
24h Volume:
73,741
Relative Volume:
0.30
Market Cap:
$82.81M
Revenue:
$17.85M
Net Income/Loss:
-$96.93M
P/E Ratio:
-
EPS:
-$2.47
Net Cash Flow:
-$88.29M
1W Performance:
-6.70%
1M Performance:
-43.14%
6M Performance:
-74.75%
1Y Performance:
-83.80%
1-Day Range:
$0.8001$0.83
1-Week Range:
$0.8001$0.919
52-Week Range:
$0.8$5.92
Nyxoah Sa Stock (NYXH) Company Profile
Market Cap
Revenue
Net Income
Cash Flow
EPS